Clinical Investigation Spclst Gurnee, IL - 60031

Clinical Investigation Spclst is categorized under Medical Labs in Gurnee, IL and active since 2000.

Clinical Investigation Spclst was established in 2000, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6219993 by the NAICS.

If you are seeking more information, feel free to contact Edward Khalil, Owner at the company’s single location by writing to 1800 Nations Drive # 115, Gurnee, Illinois IL 60031 or by phoning (847) 599-2492. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Clinical Investigation Spclst
Contact Person: Edward Khalil, Owner
Address: 1800 Nations Drive # 115, Gurnee, Illinois 60031
Phone Number: (847) 599-2492
Website Address: cisresearch.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Labs
SIC Code: 8071
NAICS Code: 6219993
Share This Business:

Clinical Investigation Spclst was started in 2000 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6219993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Edward Khalil, Owner for inquiries that concern Clinical Investigation Spclst by calling the company number (847) 599-2492, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Investigation Spclst can be found at the coordinates 42.38387,-87.94301 as well as the street address 1800 Nations Drive # 115 in Gurnee, Illinois 60031.

For its online presence, you may visit Clinical Investigation Spclst’s website at cisresearch.com and engage with its social media outlets through on Twitter and on Facebook.